How pharma could feel the pain of a recession
PharmaVoice
MARCH 21, 2025
Pharma has long been considered “recession proof,” but an economic downturn could still hurt the industry in numerous ways.
Fri.Mar 21, 2025
232 
FarmboxRx Introduces Platform for Addressing SDOH Needs
MedCity News
MARCH 21, 2025
FarmboxRx’s new platform provides tailored support to help members engage with their health benefits. The post FarmboxRx Introduces Platform for Addressing SDOH Needs appeared first on MedCity News.
Join 8,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Alnylam joins three-way contest in ATTR cardiomyopathy
pharmaphorum
MARCH 21, 2025
Alnylam has claimed FDA approval for Amvuttra in ATTR cardiomyopathy, allowing it to compete with rival therapies from Pfizer and BridgeBio.
J&J boosts US operations with $55bn investment
Pharmaceutical Technology
MARCH 21, 2025
J&J is the latest pharma company to announce a major US investment, committing to a $55bn influx in the next four years.
The Intersection of AI and Sales: Personalization Without Compromise
Speaker: Jesse Hunter and Brynn Chadwick
Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.
Fabhalta is first FDA-approved therapy for rare disease C3G
pharmaphorum
MARCH 21, 2025
Novartis' oral complement inhibitor Fabhalta has become the first approved treatment for rare kidney disease C3G as it chases a $3bn sales target
Sign up to get articles personalized to your interests!
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
More Trending
AZ builds in China, as J&J ramps up its US investments
pharmaphorum
MARCH 21, 2025
AstraZeneca will open its sixth R&D centre in China, while J&J announces four new manufacturing facilities in the US in a major reshoring drive.
FDA approves Johnson & Johnson’s Tremfya to treat Crohn’s disease
Pharmaceutical Technology
MARCH 21, 2025
J&J has received US FDA approval for Tremfya (guselkumab), to treat moderately to severely active Crohn's disease (CD) in adults.
EMA panel endorses AI for MASH clinical trials
pharmaphorum
MARCH 21, 2025
PathAI's artificial intelligence tool for diagnosing MASH has become the first to be recommended under the EMA's Qualification Opinion framework.
Global funding cuts reversing decades of tuberculosis progress, WHO says
Pharmaceutical Technology
MARCH 21, 2025
Ahead of World Tuberculosis Day on 24 March, the WHO has said that global funding cuts are curtailing efforts to fight the disease.
5 Ways You Can Win Faster with Gen AI in Sales
Advertiser: ZoomInfo
Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.
J&J adds to IL-23 options in Crohn's after FDA approval
pharmaphorum
MARCH 21, 2025
J&J's Tremfya gets a much-anticipated FDA approval for Crohn's disease, which the company thinks will be key to a renewed phase of sales growth.
Mastering compliance and copyright in healthcare and MedComms
Pharmaceutical Technology
MARCH 21, 2025
Understanding reuse rights and copyright compliance is critical, particularly in todays ever-evolving technological landscape.
APhA 2025: Pharmacists Can Prescribe Contraceptives in 30 States and the District of Columbia
Pharmacy Times
MARCH 21, 2025
Contraceptive options have expanded since 1960, with pharmacists today playing a growing role as prescribers of contraception and studies showing the benefit of pharmacist-driven contraception clinics.
European agencies catch up with speedier regulatory pathways for CGTs in the US
Pharmaceutical Technology
MARCH 21, 2025
Shorter trial authorisation timelines for ATMP trials in the US are an advantage for biotechs, say experts.
AI in Marketing & Sales: Today’s Tools, Tomorrow’s Potential
Speaker: Kevin Burke
AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.
BCMA-Targeting CAR T-Cell Therapy Is Feasible in Patients With Multiple Myeloma and CNS Involvement
Pharmacy Times
MARCH 21, 2025
Patients with central nervous system (CNS) involvement achieved favorable outcomes with chimeric antigen receptor (CAR) T-cell therapy.
PAP 2025: The Ongoing Challenge for Nonprofit Patient Assistance Programs
Pharmaceutical Commerce
MARCH 21, 2025
Jonathan James, CEO, Hope Charities, discusses the challenge of nonprofits securing sustainable funding while ensuring patients are aware of available assistance.
Heart Failure With Improved Ejection Fraction Is a Rising Focus in Cardiovascular Care
Pharmacy Times
MARCH 21, 2025
This subset of heart failure requires unique therapeutic considerations.
Johnson & Johnson to Invest Over $55 Billion in US Manufacturing Facilities
PharmExec
MARCH 21, 2025
The investment, which is a 25% increase from previous years, will support three new advanced manufacturing facilities, expansions at existing sites, and R&D efforts.
10 Ways to Leverage Buyer Signals and Drive Revenue
Advertiser: ZoomInfo
In today’s ultra-competitive markets, it’s no longer enough to wait for buyers to show obvious signs of interest. Instead, sales teams must be proactive, identifying and acting on nuanced buyer behaviors — often before prospects are fully ready to make a purchase. In this eBook from ZoomInfo & Sell Better, learn 10 actionable ways to use these buyer signals to transform your sales strategy and close deals faster.
ITT Brands’ Industry 4.0 Solutions for Flow Control to Be Shown at INTERPHEX
PharmaTech
MARCH 21, 2025
Upgraded and dynamic valve platforms as well as advanced sensing will be some of the components of ITTs exhibit.
FDA Approves Johnson & Johnson’s Tremfya for Crohn Disease
PharmExec
MARCH 21, 2025
Tremfya is the first and only IL-23 inhibitor with both subcutaneous and intravenous induction options for adults with moderately to severely active Crohn disease in the United States.
How to manage regulatory complexities with clinical trial data
Pharmaceutical Technology
MARCH 21, 2025
Clinical trials must use effective electronic data capture platforms that prioritise data integrity and comply with regulations.
Pharma Pulse 3/21/25: Pregnant Women Underrepresented in Clinical Trials, The Future of Value-Based Care & more
PharmExec
MARCH 21, 2025
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Pharma Pulse 3/21/25: The Biggest Bottlenecks for Patients, Age and Comorbidities Drive RSV Hospitalization Rates & more
Pharmaceutical Commerce
MARCH 21, 2025
The latest news for pharma industry insiders.
The Cigna Group Completes Sale of Medicare Businesses
PharmExec
MARCH 21, 2025
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
PAP 2025: Boosting Patient Empowerment
Pharmaceutical Commerce
MARCH 21, 2025
The presentation suggests ways to educate patients on the options available to them, with the hope of ultimately improving health outcomes.
Strategies to Address Rising Medication Costs & Improve Patient Access
PharmExec
MARCH 21, 2025
Kimberley Chiang, vice president of biopharma commercial solutions at CoverMyMeds, identifies innovative strategies and solutions for addressing the rising cost of medications and improving patient access.
Signal-Based Selling: How to Leverage 4 Key Buying Signals
Advertiser: ZoomInfo
As prospects define their problem, search for solutions, and even change jobs, they are generating high-value signals that the best go-to-market teams can leverage to close more deals. This is where signal-based selling comes into play. ZoomInfo CEO Henry Schuck recently broke down specific ways to put four key buying signals into action with the experts from 30 Minutes to President’s Club.
Futureproofing Pharma Supply Chains
Pharmaceutical Commerce
MARCH 21, 2025
In the fourth part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Brad Stewart, BDOs national life sciences co-leader, addresses how AI can help support pharma leaders with managing their supply chains and addressing potential material shortages.
ABPI Restores Novo Nordisk’s Membership
PharmExec
MARCH 21, 2025
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Nipocalimab Is Granted Fast Track Designation for Treatment of Patients With Sjögren’s Disease
Pharmacy Times
MARCH 21, 2025
Sjgren's disease is one of the most common chronic autoimmune diseases that affects 4 million individuals around the world.
Let's personalize your content